sorafenib has been researched along with midodrine in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (midodrine) | Trials (midodrine) | Recent Studies (post-2010) (midodrine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 526 | 118 | 230 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Deshpande, H; Patwa, H; Peixoto, AJ; Wegner Wippel, C | 1 |
1 review(s) available for sorafenib and midodrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for sorafenib and midodrine
| Article | Year |
|---|---|
Neurogenic orthostatic hypotension after treatment with sorafenib.
Topics: Humans; Hypertension; Hypotension, Orthostatic; Male; Midodrine; Sorafenib; Vascular Endothelial Growth Factor A | 2022 |